Trials / Completed
CompletedNCT04771585
Quantification of Exhaled Particles to Identify Airborne Transmission Risks of COVID-19
Quantification of Exhaled Particles to Identify Airborne Transmission Risks of SARS-Co-V-2
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Fraunhofer-Institute of Toxicology and Experimental Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
In this study, the aerosols emitted during various respiratory activities will be quantified in healthy subjects. The differences in aerosol size spectrum and number during tidal breathing, speaking, coughing and singing will be assessed. Subjects with an endogenously high aerosol emission will repeat the respiratory activities wearing face masks with varying particle filter capacity to investigate the aerosol emission reduction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Community Mask | Fabric mask, no medical device |
| OTHER | Surgical Mask | Medical face mask (personal protective equipment), CE-certified |
| OTHER | FFP2 respirator | Filtering Face Piece with no less than 94% filtering capacity, CE-certified |
| OTHER | FFP3 respirator | Filtering Face Piece with no less than 99% filtering capacity, CE-certified |
Timeline
- Start date
- 2021-03-29
- Primary completion
- 2021-08-20
- Completion
- 2021-08-20
- First posted
- 2021-02-25
- Last updated
- 2021-08-26
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04771585. Inclusion in this directory is not an endorsement.